US Patent 11819518 Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
Patent 11819518 was granted and assigned to Immatics Biotechnologies on November, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 30, 2021
0
Date of Patent
November 21, 2023
0
Patent Applicant
Patent Application Number
17245133
0
Patent Citations
•••
Patent Inventor Names
Janet Peper
0
Hans-Georg Rammensee
0
Philipp Wagner
0
Heiko Schuster
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11819518 Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.